ATLAS

Serina Therapeutics (SER) Q3 2026 earnings results

Serina Therapeutics (SER) reported EPS of -$0.31 against an analyst estimate of -$0.34: a beat of $0.03 (8.8%). The quarter ended Sep 30, 2026; the company reported on Thursday, November 19, 2026.

Status: Confirmed · 06:00 ET, Nov 19 · Source: EODHD (calendar and fundamentals, cross-checked)

Get an email before and after Serina Therapeutics reports, free with your ATLAS account

Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.

Create free account

SER Q3 2026 results at a glance

EPS reported-$0.31
EPS estimate-$0.34
SurpriseBeat · +$0.03 (+8.8%)
Quarter endedSep 30, 2026
ReportedNov 19, 2026
StatusConfirmed · 06:00 ET, Nov 19

EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Serina Therapeutics’s Q3 2026, a calendar-year company.

Serina Therapeutics EPS surprise history: last 6 quarters

Serina Therapeutics beat the EPS estimate in 3 of its last 6 reports, with an average surprise of -15.4%.

Report dateEPS est.EPS actualSurpriseResultMove*
Nov 19, 2026-$0.34-$0.31+8.8%Beat–
Aug 13, 2026-$0.35-$0.52-48.6%Miss-1.8%
May 14, 2026-$0.44-$0.53-20.5%Miss-4.7%
Nov 13, 2025-$0.53-$0.51+3.8%Beat-2.5%
Aug 11, 2025-$0.42-$0.66-57.1%Miss+7.1%
May 8, 2025-$0.62-$0.49+21.0%Beat-2.0%

*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.

SER stock reaction to the report

The price reaction will be added after the Nov 20, 2026 close.

This section appears once a post-report closing price exists and updates with every new close.

Next SER earnings report

Serina Therapeutics has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the SER earnings calendar.

ATLAS fair value and signal for SER

Last price$1.20 (-11.1%)
Chance of a higher close in 1 month45% (normal range $1.00–$1.36)

These are model outputs from the same valuation and calibrated model as the Serina Therapeutics stock page. They describe an ordinary period and are not a forecast of any particular outcome.

Serina Therapeutics Q3 2026 earnings: frequently asked questions

Did Serina Therapeutics beat earnings estimates for Q3 2026?

Serina Therapeutics reported EPS of -$0.31 against an analyst estimate of -$0.34: a beat of $0.03 (8.8%).

When did Serina Therapeutics report Q3 2026 results?

Serina Therapeutics reported on Thursday, November 19, 2026, for the quarter ended Wednesday, September 30, 2026.

How often does SER beat EPS estimates?

In its last 6 reports with a recorded result, Serina Therapeutics beat the EPS estimate 3 times; the average surprise was -15.4%. Past results do not predict the next one.

How does ATLAS confirm a result?

A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.

Educational information, not investment advice. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy